| Name | saflufenacil |
|---|---|
| Synonyms |
N’-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzoyl}-N-isopropyl-N-methylsulfamide
benmihuangcaoan Pyridine,2-chloro-5-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl] 2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-N-[methyl(propan-2-yl)sulfamoyl]benzamide 2-chloro-5-[(tetrahydro-2-pyranyloxy)methyl]pyridine 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide 2-chloro-5-(tetrahydropyran-2-yl)oxymethylpyridine (rac)-2-chloro-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-pyridine 2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]-N-[methyl(propan-2-yl)sulfamoyl]benzamide |
| Density | 1.542g/cm3 |
|---|---|
| Melting Point | 189.9-193.4 °C |
| Molecular Formula | C17H17ClF4N4O5S |
| Molecular Weight | 500.85200 |
| Exact Mass | 500.05400 |
| PSA | 122.35000 |
| LogP | 3.31790 |
| Index of Refraction | 1.56 |
| Symbol |
GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H410 |
| Precautionary Statements | P273-P501 |
| Hazard Codes | N |
| Risk Phrases | 50/53 |
| Safety Phrases | 61 |
| RIDADR | UN 3077 9 / PGIII |
|
~86%
372137-35-4 |
| Literature: BASF Aktiengesellschaft Patent: WO2005/54208 A1, 2005 ; Location in patent: Page/Page column 36 ; |
|
~45%
372137-35-4 |
| Literature: Schmidt, Thomas; Gebhardt, Joachim; Loehr, Sandra; Keil, Michael; Wevers, Jan Hendrik; Erk, Peter; Saxell, Heidi Emilia; Hamprecht, Gerhard; Mayer, Guido; Wolf, Bernd; Cox, Gerhard; Michel, Alfred; Seitz, Werner; Zagar, Cyrill; Reinhard, Robert; Sievernich, Bernd Patent: US2010/35905 A1, 2010 ; Location in patent: Page/Page column 7 ; |
|
~60%
372137-35-4 |
| Literature: BASF Aktiengesellschaft Patent: WO2005/54208 A1, 2005 ; Location in patent: Page/Page column 34-35 ; |
| Precursor 5 | |
|---|---|
| DownStream 0 | |